These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18037967)

  • 1. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
    Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
    Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
    Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
    Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.
    Shen H; Morrison CD; Zhang J; Underwood W; Yang N; Frangou C; Eng K; Head K; Bollag RJ; Kavuri SK; Rojiani AM; Li Y; Yan L; Hill A; Woloszynska-Read A; Wang J; Liu S; Trump DL; Candace JS
    Oncotarget; 2013 Nov; 4(11):2124-34. PubMed ID: 24231253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.
    Olsson AY; Feber A; Edwards S; Te Poele R; Giddings I; Merson S; Cooper CS
    Oncogene; 2007 Feb; 26(7):1028-37. PubMed ID: 16909110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and overexpression of E2F3 in human bladder cancer.
    Feber A; Clark J; Goodwin G; Dodson AR; Smith PH; Fletcher A; Edwards S; Flohr P; Falconer A; Roe T; Kovacs G; Dennis N; Fisher C; Wooster R; Huddart R; Foster CS; Cooper CS
    Oncogene; 2004 Feb; 23(8):1627-30. PubMed ID: 14716298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
    Li X; Han X; Yang J; Sun J; Wei P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1360-1364. PubMed ID: 29169421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rb knockdown accelerates bladder cancer progression through E2F3 activation.
    Wang JP; Jiao Y; Wang CY; Xu ZB; Zhang B
    Int J Oncol; 2017 Jan; 50(1):149-160. PubMed ID: 27922689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of 6p22 genomic gain in retinoblastoma.
    Orlic M; Spencer CE; Wang L; Gallie BL
    Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.
    Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA
    Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
    Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
    Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index.
    Wright C; Thomas D; Mellon K; Neal DE; Horne CH
    Br J Urol; 1995 Feb; 75(2):173-9. PubMed ID: 7850321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
    Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
    Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
    Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
    J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer].
    Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R
    Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development.
    Chong JL; Tsai SY; Sharma N; Opavsky R; Price R; Wu L; Fernandez SA; Leone G
    Mol Cell Biol; 2009 Jan; 29(2):414-24. PubMed ID: 19015245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Oeggerli M; Tomovska S; Schraml P; Calvano-Forte D; Schafroth S; Simon R; Gasser T; Mihatsch MJ; Sauter G
    Oncogene; 2004 Jul; 23(33):5616-23. PubMed ID: 15122326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression.
    Xu HJ; Cairns P; Hu SX; Knowles MA; Benedict WF
    Int J Cancer; 1993 Mar; 53(5):781-4. PubMed ID: 8449603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
    Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
    J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F3b over-expression in ovarian carcinomas and in BRCA1 haploinsufficient fallopian tube epithelium.
    Smith NL; Welcsh P; Press JZ; Agnew KJ; Garcia R; Swisher EM
    Genes Chromosomes Cancer; 2012 Nov; 51(11):1054-62. PubMed ID: 22887716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.